Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell P Levesque

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
Nature Cancer|January 17, 2024
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomasAhmed M O Elbatsh, Ali Amin-Mansour, Anne Haberkorn, et al.
Oncotarget|October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibitionGongda Xue, Reto Kohler, Fengyuan Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK InhibitorsAndrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Cancer Cell|June 18, 2021
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanomaOskar Marin-Bejar, Aljosja Rogiers, Michael Dewaele, et al.
Nature Medicine|October 20, 2020
Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant stateDaniela Cerezo-Wallis, Marta Contreras-Alcalde, Kevin Troulé, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanomaFlorian Märkl, Mohamed-Reda Benmebarek, Julius Keyl, et al.
Nature Communications|June 11, 2026
Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanomaAndrea Di Pietro, Lewis Au, Patrick Crock, et al.
Developmental Cell|September 16, 2021
Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formationNathaniel R Campbell, Anjali Rao, Miranda V Hunter, et al.
Cancer Research|March 22, 2023
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M Eichhoff, Corinne I Stoffel, Jan Käsler, et al.
EMBO Molecular Medicine|November 15, 2023
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibitionSarah Proteau, Imène Krossa, Chrystel Husser, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Nature Cancer|January 17, 2024
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomasAhmed M O Elbatsh, Ali Amin-Mansour, Anne Haberkorn, et al.
Oncotarget|October 21, 2017
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibitionGongda Xue, Reto Kohler, Fengyuan Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK InhibitorsAndrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Cancer Cell|June 18, 2021
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanomaOskar Marin-Bejar, Aljosja Rogiers, Michael Dewaele, et al.
Nature Medicine|October 20, 2020
Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant stateDaniela Cerezo-Wallis, Marta Contreras-Alcalde, Kevin Troulé, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanomaFlorian Märkl, Mohamed-Reda Benmebarek, Julius Keyl, et al.
Nature Communications|June 11, 2026
Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanomaAndrea Di Pietro, Lewis Au, Patrick Crock, et al.
Developmental Cell|September 16, 2021
Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formationNathaniel R Campbell, Anjali Rao, Miranda V Hunter, et al.
Cancer Research|March 22, 2023
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M Eichhoff, Corinne I Stoffel, Jan Käsler, et al.
EMBO Molecular Medicine|November 15, 2023
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibitionSarah Proteau, Imène Krossa, Chrystel Husser, et al.
Pageof 21